Mice with mutations in the Dystrophin (DMD), Calpain-3 (LGMD2A) or Dysferlin (LGMD2B) genes are susceptible to malignant tumours originating from the skeletal muscles 1–4 (reviewed in 5). This evidence concerns the gene CAPN3 and neoplasm.